InvestorsHub Logo
Followers 4
Posts 197
Boards Moderated 0
Alias Born 10/25/2010

Re: TallyNole post# 67288

Tuesday, 06/17/2014 10:56:50 AM

Tuesday, June 17, 2014 10:56:50 AM

Post# of 79678
Coincidentally, the pharma company making such a drug for epilepsy also reported good news today:

"GW Pharmaceuticals PLC- ADR (NASDAQ:GWP*) reports preliminary data on 27 children and young adults with treatment-resistant epilepsy who have been treated with its investigational cannabidiol product candidate Epidiolex for a period of 12 weeks. Of the 27 patients, nine have Dravet syndrome and the remaining 18 have treatment-resistant epilepsies with convulsive and/or non-convulsive siezures.The mean overall reduction in seizure frequency compared to baseline was 44%."

I bought this stock a year or so ago at $8 and sold it at $11. What a dope.